NCT02662608
- Conditions
- Adenocarcinoma, Adenoid Cystic Carcinoma, Carcinoma, +4 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Adenocarcinoma
Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.
5,040 public trials
1,178 recruiting studies
Adenocarcinoma trial results
NCT02442661
- Conditions
- Adenocarcinoma, Adenocarcinoma, Papillary, Carcinoma, +11 more
- Locations
-
- Rebecca J Guigli Aurora, Colorado, United States
NCT01908166
- Conditions
- Adenocarcinoma, Adult Primary Liver Cancer, Carcinoma, +20 more
- Locations
-
- Stanford University, School of Medicine Stanford, California, United States
NCT00550537
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, +14 more
- Locations
-
- University of Florida Shands Cancer Center Gainesville, Florida, United States
- Emory University Atlanta, Georgia, United States
- University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States
- Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States
NCT02762721
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +10 more
- Locations
-
- Atlanta, Georgia, United States
- Seattle, Washington, United States
- Rozzano, MI, Italy
- Benevento, Italy
NCT01927887
- Conditions
- Adenocarcinoma, Adenocarcinoma, Papillary, Carcinoma, +20 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
NCT00026533
- Conditions
- Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +19 more
- Locations
-
- Albert B. Chandler Medical Center, University of Kentucky Lexington, Kentucky, United States
Completed
Combined HCC-MFCCC
NCT03178409
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
- Locations
-
Not specified
NCT03171428
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
- Locations
-
Not specified
Completed
Evaluate Safety and Tolerability in Dose Escalation of Sorafenib in Advanced Renal Cell Cancer
NCT01189370
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- University of Kansas Medical Center Kansas City, Kansas, United States